Joe Biden’s scientific advisers will meet with vaccine makers in coming days as the presidential transition remains stalled because of President Donald Trump’s refusal to acknowledge that he lost the election.
That delayed handoff to the next administration is especially problematic during a public health crisis, the government’s top infectious disease expert said.“Of course it would be better if we could start working with them,” said Dr.
Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases who has been through many presidential transitions during 36 years of government service.